Pancreaticoduodenectomy (PD) is the primary of surgical therapy for patients with resectable pancreatic head cancers (PC) and other periampullary pathologies. Numerous studies have emphasized several key advantages of minimally invasive pancreaticoduodenectomy (MIPD), including reduced estimated blood loss (EBL), shorter length of stay, and improved oncological outcome compared with the conventional open approach.
1 However, the feasibility and relative advantages between the two main MIPD procedures, namely laparoscopic PD (LPD) and robotic PD (RPD), are still debated. Although some studies have been published on the surgical efficacy of MIPD, short- or long-term outcome superiority of one approach over the other focusing on PC has not been established.
2,3 …